Kardigan KARD
NASDAQ KARD
$13.82 -0.30 (-2.12%)
At close: Nov 13, 2026 · 4:00 PM EST

Kardigan (KARD) Net Equity Issued and Repurchased (2025 - 2026)

Updated

Kardigan's Net Equity Issued and Repurchased came in at -$427.6 million for Q3 2026, compared with $242.91 million a year earlier.

Analysis

Kardigan (KARD) Net Equity Issued and Repurchased (2025 - 2026) Analysis & Trends

Over the trailing twelve months to Sep 30, 2026, Kardigan reported Net Equity Issued and Repurchased of $122.51 million; for FY2025, it was $454.17 million, up 335.0% from FY2024.

  • Going back by year, Net Equity Issued and Repurchased was $104.41 million in FY2024.
  • Business Quant data shows KARD's Net Equity Issued and Repurchased at $428.61 million (Q2 2026), $10.42 million (Q1 2026) and $111.08 million (Q4 2025) in the three quarters before Q3 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Equity Issued (Qtr)
1 Eli Lilly 1,359.75 Bn 1,333.37 Bn 20.46 Bn -377.00 Mn
2 Johnson & Johnson 688.76 Bn 608.62 Bn 17.30 Bn -966.00 Mn
3 AbbVie 521.69 Bn 489.75 Bn 13.12 Bn -5.00 Mn
4 Merck 364.31 Bn 327.31 Bn 13.19 Bn -406.00 Mn
5 Novartis Ag 306.35 Bn 279.93 Bn - -
6 Astrazeneca 285.96 Bn 259.56 Bn 13.26 Bn 4.00 Mn
7 Amgen 251.88 Bn 203.53 Bn 7.58 Bn -
8 Gilead Sciences 208.59 Bn 183.61 Bn 6.73 Bn -283.00 Mn
9 Pfizer 164.73 Bn 112.38 Bn 12.56 Bn -
10 Kardigan 1.29 Bn -398.44 Mn - -427.60 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 -427.60 Mn
Jun 30, 2026 428.61 Mn
Mar 31, 2026 10.42 Mn
Mar 31, 2025 100.00 Mn
API Access

Kardigan Net Equity Issued and Repurchased API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=KARD&period=max&api_key=YOUR_API_KEY